Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 1/20 | 0.36 |
| ▸ | HTR2B | P41595 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 2/20 | 0.33 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.32 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.32 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.32 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.32 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.32 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31444476 | 0.84 | OPRL1 (0.34) | CHRNB2CHRNA4 | |
| SCHEMBL2328899 | 0.73 | RAD52 (0.38) | HTR2CHTR2BSLC6A2SLC6A4SLC6A3 | |
| SCHEMBL24774588 | 0.73 | ADAM10 (0.33) | HTR2CCHRNB2CHRNA4 | |
| SCHEMBL3396699 | 0.68 | PRCP (0.40) | — | |
| SCHEMBL31444531 | 0.68 | MEN1 (0.43) | HTR2CHTR2BCHRNB2CHRNA4 | |
| SCHEMBL22455759 | 0.68 | MEN1 (0.43) | HTR2CHTR2BCHRNB2CHRNA4 | |
| SCHEMBL31738967 | 0.68 | MEN1 (0.43) | HTR2CHTR2BCHRNB2CHRNA4 | |
| SCHEMBL29588230 | 0.68 | MEN1 (0.43) | HTR2CHTR2BCHRNB2CHRNA4 | |
| SCHEMBL31444475 | 0.67 | MEN1 (0.42) | HTR2CHTR2BTP53SLC6A2SLC6A4 | |
| SCHEMBL18588947 | 0.67 | HTR2C (0.41) | HTR2CHTR2BSLC6A2SLC6A4SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025072451-A1 | RAS-PI3K INHIBITORS FOR THE TREATMENT OF CANCER AND IMMUNOLOGICAL DISEASES | VIVIDION THERAPEUTICS, INC. (US) | 2025-04-03 | — | — | WO | disclosed |